"V体育平台登录" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure V体育官网. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. .

Review
. 2019 Feb 7;18(1):21.
doi: 10.1186/s12943-019-0950-1.

V体育官网 - Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues

Hongqing Zhuang  1   2 , Siyu Shi  3 , Zhiyong Yuan  4 , Joe Y Chang  5
Affiliations
Review

"VSports" Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues

Hongqing Zhuang et al. Mol Cancer. .

Abstract

Vascular damage is followed by vascular endothelial growth factor (VEGF) expression at high levels, which is an important mechanism forradiation brain necrosis development. Bevacizumab alleviates brain edema symptoms caused by radiation brain necrosis through inhibiting VEGF and acting on vascular tissue around the brain necrosis area. Many studies have confirmed that bevacizumab effectively relieves symptoms caused by brain necrosis, improves patients' Karnofsky performance status (KPS) scores and brain necrosis imaging. However, necrosis is irreversible, and hypoxia and ischemia localized in the brain necrosis area may easily lead to radiation brain necrosis recurrence after bevacizumab is discontinued. Further studies are necessary to investigate brain necrosis diagnoses, bevacizumab indications, and the optimal mode of administration, bevacizumab resistance and necrosis with a residual or recurrent tumor VSports手机版. .

Keywords: Bevacizumab; Drug resistance; Indication; Radiation brain necrosis V体育安卓版. .

PubMed Disclaimer

Conflict of interest statement (VSports app下载)

Ethics approval and consent to participate

Not applicable.

Consent for publication

All authors agree to publish in the magazine. All authors read and approved the final manuscript V体育ios版.

Competing interests

None.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures (VSports最新版本)

Fig. 1
Fig. 1
Mechanisms for bevacizumab treatment of radiation brain necrosis
See this image and copyright information in PMC

References

    1. Gonzalez J, Kumar AJ, Conrad CA, Levin VA. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys. 2007;67(2):323–326. doi: 10.1016/j.ijrobp.2006.10.010. - V体育安卓版 - DOI - PubMed
    1. Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neuro-Oncol. 2009;94(1):63–68. doi: 10.1007/s11060-009-9801-z. - DOI - PubMed
    1. Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T, et al. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol. 2013;43(3):337–341. doi: 10.1093/jjco/hys231. - V体育官网 - DOI - PubMed
    1. Boothe D, Young R, Yamada Y, Prager A, Chan T, Beal K. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. Neuro-Oncology. 2013;15(9):1257–1263. doi: 10.1093/neuonc/not085. - DOI - PMC - PubMed
    1. Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E, et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res. 2012;17:25. doi: 10.1186/2047-783X-17-25. - DOI - PMC - PubMed

VSports最新版本 - Publication types

MeSH terms (V体育ios版)

"VSports手机版" Substances

LinkOut - more resources